• DehydraTECH™ drug delivery platform achieved a 319% higher CBD blood concentration level at 60 minutes than the generic coconut oil formulation
• The technology can be used on the nicotine market, the pharmaceutical market, and the cannabinoid market
• No other company in the world has a patent for improved delivery of all non-psychoactive cannabinoids
• Partnership with one of the world’s largest tobacco companies with up to $12 million in Lexaria funding for clinical investigations and product development

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has launched a revolutionary technology that accelerates intestinal absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sweeteners or sugars, and other unhealthy practices. It is applicable to absorption of cannabis and nicotine, among other bioactive substances.

According to company data, DehydraTECH™ can be used successfully in multiple industries, including the nicotine market (estimated at approximately $746 billion), the pharmaceutical market (more than $68 billion), as well as the cannabinoid market (estimated at over $10.5 billion) (http://ibn.fm/NpNF4).

DehydraTECH™ is patented for all non-psychoactive cannabinoids as well as for tetrahydrocannabinol (THC) and psychoactive cannabinoids. The platform reduces the time of onset of THC by four times on average (http://ibn.fm/NzcIR).

Lexaria is the only company in the world that holds patents for oral delivery of all cannabinoids and nicotine. The company has been awarded 16 patents in the United States and Australia and holds 60 globally pending patents. Recently, Lexaria obtained two patents for treating certain conditions including, but not limited to heart disease, neurological diseases such as Alzheimer’s, Parkinson’s, schizophrenia, and others. The platform has potential applications to treat the common form of dementia as well as other nervous system diseases.

The company has developed its technology based on recognition of the fact that inhalation of drugs into the lungs can be dangerous. Edible ingestion enables much healthier and safer absorption. The platform has also been proven to deliver up to 10 times more of active ingredients than traditional edibles. DehydraTECH™ is the first platform that makes it possible to avail many of the benefits of inhalation while greatly reducing the risks.

Medical researchers have struggled to find ways to penetrate the blood brain barrier effectively to transport beneficial drugs for many years. This barrier exists to block toxic or otherwise dangerous substances from entering the brain and is formed by layers of microvascular endothelial cells inside blood vessels. Lexaria’s DehydraTECH™ drug delivery platform brings beneficial drugs to the brain faster.

In June 2019, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH™ technology. This series built on the company’s original, independent, third-party laboratory in vitro lab experiments began in 2015, which showed utilization of the DehydraTECH™ drug delivery platform increased the absorption levels of cannabidiol (CBD) in human intestinal cells by an impressive 499%. The results of the studies showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH™ technology in comparison with generic industry MCT coconut-oil formulations. Moreover, the animal studies using the enhanced formulation showed an 811% increase of CBD delivery into the blood in comparison with generic MCT coconut-oil formulations.

Additionally, Lexaria recently partnered with one of the world’s largest tobacco companies, which is providing up to $12 million to fund 100% of Lexaria’s portion of the obligations for clinical investigations and development of oral forms of nicotine delivery using the DehydraTECH™ drug delivery platform (http://ibn.fm/JZBKX).

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Plus Products boasts best-selling cannabis product in California in 2019
• Company recently announced transition to HERBL Distribution Solutions as main California distribution partner
• PLUS is growing brand, focusing on both current and new market opportunities

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a hemp and cannabis food company using nature to bring balance to consumers’ lives, is on a mission to make cannabis safe and approachable. PLUS(TM) is working to build the world’ strongest cannabis brand. Headquartered in San Mateo, California, the company focuses on producing edibles using extracts to ensure compliant, dosable and appetizing products that provide a consistent cannabis experience.

PLUS’s products are ranked as one of the top edibles brands in the state of California, which is the largest legal cannabis market in the United States. The company has the state’s best-selling cannabis product, as well as the best-selling gummies brand in California. At present, PLUS products are available in 360 licensed retailers in the state, and PLUS has sold more than 2.5 million branded units since January 1, 2018 (http://ibn.fm/wtvy4).

Recently, Plus Products announced its transition to HERBL Distribution Solutions as its chief California distribution partner, along with the termination of its distribution relationship with Calyx Brands Inc. HERBL is a leader in the California marketplace with active distribution to more than 600 licensed retailers across the state. PLUS’ internal sales team is working directly with HERBL’s team to facilitate a speedy and efficient transition for PLUS’ current retail partners and to open new accounts moving ahead (http://ibn.fm/wn37D).

“After an extensive review of the major California cannabis distributors, we determined that HERBL was best positioned to scale with PLUS and reliably deliver product to retailers at the lowest cost,” PLUS co-founder and CEO Jake Heimark stated in a news release. “Their substantial market reach and world-class management team give us confidence that they will help PLUS further solidify our position as the largest cannabis-infused gummies brand in California.”

In California, PLUS has established its iconic product: PLUS Gummies (cannabis infused). Its Plus Uplift Sour Watermelon was the best-selling cannabis product in California in 2019.

Of note to investors is that Plus Products is centered on quality growth in California and beyond. Its emphasis is on thoughtfully building a brand in a strategic, deliberate approach. The company is growing its brand through new markets, new products and new consumers.

Plus Products continues to be driven by its dedication to premier dosable products. For investors, PLUS is marketing creatively including product launch partnerships with American Superstar John Legend and direct-to-consumer sleep pioneer Casper. PLUS recently entered the National Hemp CBD market expected to exceed $20 billion by 2022.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• SHRG posts record Q2 revenues, cumulative sales of $169 million since launching proprietary line of products.
• CEO says record sales demonstrate that SHRG sales, support strategies are on the right path.
• Company officials believe SHRG will be able to fund working capital needs for the next year with existing cash and cash equivalents with cash provided through operations and secured and unsecured debt, including through issuance of convertible notes and short-term borrowings under financing arrangements and occasional capital transactions

In its most recent SEC filing, Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company in the direct-selling industry, posted record Q2 revenues and cumulative sales of $169 million since the company launched its own proprietary line of products (http://ibn.fm/fqmLo). Specifically, the company reported record-breaking revenues of $38.9 million for its fiscal quarter ended October 31, 2019, more than double the $18 million revenues reported in the comparable quarter of fiscal 2019.

“Product sales for our incredible health and wellness products of Elevacity Global continue to be strong, consistently increasing each quarter,” SHRG CEO John “JT” Thatch stated in a news release. “Our Q2 revenues demonstrate that our sales and support strategies are on the right path as we continue to grow in the direct selling marketplace. We attribute our success to our independent distributors, which we refer to as Elepreneurs, and our incredible team at the corporate offices.”

SHRG’s financial numbers were reported in its most recent quarterly report filed with the Securities and Exchange Commission (http://ibn.fm/ZAbhv), which noted that “the accompanying consolidated financial statements have been prepared on a going concern basis, which assumes the company will be able to realize its assets and settle its liabilities in the ordinary course of its business for the foreseeable future.”

Noting that the company is an emerging growth company and, prior to its fiscal quarter ended January 31, 2018, it had virtually no sales, the filing then reported that SHRG’s “quarterly net sales have increased, and gross margin has expanded each quarter since the December 2017 launch of its Elevate health and wellness product line. For the full fiscal year ended April 30, 2019, cash provided by operations was $6.0 million on annual sales of $85.9 million. In addition, for the six months ended October 31, 2019, cash provided by operations was $12.1 million on sales of $74.3 million, while operating earnings were $3.9 million. As of October 31, 2019, cash and cash equivalents were $12.8 million.”

In the filing, company officials reported that they believe SHRG will be able to fund working capital needs for the next year with existing cash and cash equivalents, with cash provided through operations and secured and unsecured debt, including through the issuance of convertible notes and short-term borrowings under financing arrangements and capital transactions from time to time. “The company believes there is no longer reasonable doubt as to [its] ability to continue as a going concern in the foreseeable future,” the filing noted.

“SHRG will continue its efforts to expand revenues through its subsidiaries by added support, expansion efforts and by bringing on additional experienced industry talent to help these efforts on a large scale,” Thatch stated in a news release. “The company will continue to evaluate its expansion plans, products and strategies to continue its success as we enter into 2020.”

Sharing Services Global Corporation is a diversified company, with Elepreneurs Holdings and Elevacity Holdings being its primary operating subsidiaries. SHRG markets and distributes health and wellness products that are sold under the Elevate brand through an independent sales force of distributors, or Elepreneurs, using the direct-selling business model. Sharing Service’s current product offerings include its Elevate health and wellness product line, launched in December 2017. The company’s Elevate product line consists of nutraceutical products referred to as D.O.S.E., which refers to the key hormones dopamine, oxytocin, serotonin, and endorphins.

Sharing Services is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• The company aims to promote cannabinoid-infused beverages without adverse side effects, superior to most analogical products, to potentially replace alcohol
• Expanding on development of infusion technologies to include exotic cannabinoids, such as CBN and THC-V, which may improve sleep and control appetite
• Global industrial hemp market is expected to grow to $26.6 billion by 2025 at CAGR of 34.0%

Cannabinoid science innovator MCTC Holdings Inc. (OTC: MCTC), doing business as Cannabis Global, Inc., is undergoing a rebranding process with the goal of developing unique products that will allow it to take advantage of cannabis industry opportunities while avoiding overcrowded and potentially problematic niches like retail and cultivation, according to CEO and Chairman Arman Tabatabaei in an exclusive interview with NetworkNewsWire (http://ibn.fm/7O6d5).

Ever since the company’s reorganization in June 2019, its rebranding has focused on developing unique cannabis-related intellectual properties, products, and technologies (http://ibn.fm/lXQlz). According to its CEO, the company is targeting the middle part of the market, specifically the post-processing of refined hemp products. MCTC aims to process refined products such as hemp isolates and distillates using special delivery systems, on which the company has filed patents, and sell them through food, beverage and consumer brands.

One of the company’s revolutionary brands is “Hemp You Can Feel™,” based on an alcohol beverage replacement technology that is unique in the way it is delivered to the body. When consuming hemp extract conventionally, people tend not to feel the effects at once and aren’t motivated to keep taking it. With Hemp You Can Feel™, the consumer enjoys a relaxed sensation with none of the downsides of alcohol consumption. “Probably the most remarkable feat we have accomplished in the laboratory is that while the products are based on hemp extracts, the levels are so low that they are undetectable in industry tests,” Tabatabaei said in the interview.

The company has filed a patent on this delivery technology, which covers aspects of nanoparticles and nanofibers comprising one or more cannabinoids disposed within a water-soluble medium. Using this method, the substance is delivered to the body in small amounts and maximally absorbed as a result. What is more, the development of novel polymeric nanofibers and nanoparticles will allow for potentially adjustment of cannabinoid combinations, extremely high loading rates, controlled release parameters, and precise dosing all at the same time.

Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and tetrahydrocannabivarin (THC-V), including their potential effects on sleep and appetite suppression. There is currently very little research into these two cannabinoids, Tabatabaei said. “We don’t want to divulge too much about the research direction, but we’re going to be producing some delivery systems that we think will be extremely innovative. A lot of research needs to be done in these areas,” he added.

MCTC Holdings is a Delaware registered, fully reporting and audited publicly traded company. With the hemp industry moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp value chain. The company plans to actively pursue R&D programs and productization for exotic extract isolation, bioenhancement of hemp extracts and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing hemp sector. The company is headed and managed by a group of highly experienced hemp and cannabis industry pioneers and entrepreneurs.

The company is focused on multiple growing verticals within the global cannabis and CBD industry. Through strategic partnerships, acquisitions, and the development of intellectual property, MCTC seeks to position itself as a leading provider of innovative and unique hemp-related products and technologies on the fast-growing global industrial hemp market, projected to reach $26.6 billion by 2025 from 4.6 billion in 2019, expanding at a CAGR of 34 percent (http://ibn.fm/A3xjj).

For more information, visit the company’s website at www.CannabisGlobalInc.com

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

• Global vacation rental market is predicted to reach $63 billion in five years
• InsuraGuest’s InsurTech platform covers a wide range of liablities, including accidental damage to rooms, lost or stolen items, medical expenses, death or dismemberment
• Platform has potential to access millions of properties worldwide

Unforeseen events can be costly for any vacation rental property owner. From property damage to stolen goods and more, there are many issues that can affect both the property owner or host and the guests of a vacation rental.

Sadly, there isn’t much that can be done to resolve these issues once they have become fact. The only solution is to ensure that the property is under adequate protection via a specialized insurance policy. And given that traditional insurance doesn’t typically cover a wide range of events that can affect a vacation rental property, owners need to look towards short-term rental insurance policies. Here are 5 questions to ask when looking for a short-term rental insurance policy to ensure you are getting the best possible coverage.

1. Why Should I Get a Short-Term Rental Insurance Policy?

This is the obvious first question. Short-term rental insurance is often cheaper than commercial or landlord property insurance and specifically tailored to cover short-term rental needs. A homeowner’s policy rarely provides full coverage, meaning additional protection is necessary. Few things can feel as disheartening as renting to earn a bit of money, then have to spend it on getting your belongings repaired or replaced.

Service-as-a-software (SaaS) company InsuraGuest Inc.’s Guest Protection Policy, sold to hotels and vacation rental properties through its proprietary InsurTech software platform, and extended to the guest from the time of check-in to check-out. It covers a wide range of liabilities, such as accidental damage to rooms, lost or stolen items, medical expenses, death or dismemberment.

InsuraGuest is complimentary to your current Homeowners and or General Liability insurance coverage. It becomes the first line of defense for the guest, which results in the first line of defense for the property.

2. How Much Will It Cost?

To figure out how much the short-term rental insurance policy will end up costing you, consider the cost of premiums (your monthly, biannual, or annual payment), the amount of liability coverage or coverage for damaged property, and your deductible. Your deductible is the amount you’ll have to pay before the insurance provider pays for a claim.

3. What Does the Policy Cover?

Liability coverage covers medical costs incurred if your guests are injured on your property. Vacation rental insurance reduces the cost of repair and replacement and recovers losses due to theft or damage to your personal property and belongings. Homeowners insurance won’t cover damages to the guests or to the property when it is being rented out.

4. Am I Choosing the Best Company?

To make sure you’re getting the best provider, ask whether they offer the specific type of coverage you need and how long they have been on the market. You need to be sure the provider is financially stable enough to cover a claim. Another thing to look for is good reviews from existing customers. It’s important to be able to get in touch with an agent or customer service easily if you have any questions. You should also ask whether you might qualify for any discounts, or who is going to pay for the coverage. With companies like InsuraGuest, the premium payment is a pass through for the property to the guest at the time of check-in.

5. How Do I Get the Right Coverage and Quotes?

How much coverage is enough? It’s a good idea to consult a professional, ideally an independent agent. That way you know what the rules for your state are and you’re getting the most current and accurate information. You need adequate coverage before you start receiving guests, even if you decide to buy a policy for home-sharing rentals.

Facts About the Vacation Rental Industry

The global vacation rental market is expanding rapidly, being projected to reach nearly $63 billion from 2020 to 2024, with a year-over-year growth rate for 2020 estimated at 5.51%. In 2019, vacation rental revenues are expected to reach $57.669 billion, from an estimated 297.17 million total vacation rental users worldwide. The entire vacation rental market is expected to topple the hotel industry by 2020 (http://ibn.fm/tHw46).

InsuraGuest has outstanding prospects on the global market, intending to expand the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, as well as Asia before mid-2020. The company currently provides coast-to-coast coverage in the U.S.

With the U.S. accounting for 20 percent of all vacation rental properties and Europe accounting for 60 percent, and Europe, Asia and the U.S. having a combined 6.5 billion hotel nights stayed, InsuraGuest will have access to a massive demographic and more than double its vacation rental opportunities. With the ability to easily integrate with most properties’ management systems, the InsurTech platform has the potential to access millions of properties worldwide.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• SRAX’s BIGtoken platform allows consumers to own, monetize their data
• BIGtoken mobile app conducts surveys that gather valuable information
• Recently, BIGtoken surveyed more than 25,000 Americans about political issues, revealing relevant issues in upcoming presidential election

SRAX Inc. (NASDAQ: SRAX) uses its BIGtoken app to help consumers both own and get paid for their data. While major companies such as Snapchat, Facebook and Twitter make enormous amounts of money through data collection and advertisements, consumers do not receive any compensation for providing that data. Moreover, in recent years, concerns have been growing over data privacy. SRAX is evening the playing field by allowing consumers to both privatize and monetize their data.

BIGtoken’s innovative approach to data collection has led to the completion of valuable and high-quality surveys. The platform currently has more than 16 million users worldwide (http://ibn.fm/7Y3sO). These engaged consumers can feel safe providing accurate information, knowing that the data is anonymized before access to it is sold. SRAX is providing a unique experience, as this consumer control is unprecedented among large social media platforms and data brokers that sell people’s personal data to a number of interested buyers without anonymizing that data.

SRAX recently released a survey that contained revealing information about political issues that is highly relevant in the upcoming presidential election. More than 25,450 Americans took the survey on the BIGtoken mobile app. Survey results provided several insightful takeaways.

In this survey, 59% of respondents – the majority being women – said that President Donald Trump should be impeached. The survey also showed that important topics for women in particular in the upcoming election include health care costs (76%), universal health care (70%), student loans (67%) and immigration (63%). Interestingly, the survey also showed that half of women are unconcerned by the gender gap, and only 19% of the women surveyed felt that there were too few women in government.

These kinds of surveys provide invaluable information. Using the BIGtoken app, everyone, including consumers, benefit from the collected data. SRAX COO Kristoffer Nelson believes that “it’s critical to keep an eye on changing attitudes, and platforms like BIGtoken provide an ideal mechanism for brands and businesses to measure the pulse of today’s consumers.”

After downloading the BIGtoken app, a person can immediately start earning rewards by taking surveys, answering quick consumer questions and more. This information is then sold to advertisers and media companies so that they can use transparent, verified consumer data to improve their marketing approaches. SRAX is working toward creating the most valuable opted-in data set in the world.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Company CEO Riggs Eckelberry talks about recent big win in Spain
• OriginClear business model creates licensing agreements with diverse industries that create applications of proprietary water-treatment technology
• OriginClear empowers businesses to take control of their water while also helping improve their environmental, social and governance (ESG) standings

A foremost provider of water-treatment solutions, OriginClear Inc. (OTC: OCLN) offers modular water-treatment and conveyance products that enable water independence and help make clean water available for all. Recently, the company’s CEO Riggs Eckelberry was featured in a television interview discussing OriginClear’s recent success and upcoming initiatives.

During the interview, Eckelberry noted the company’s big win in Spain, where Depuporc, a Spanish enterprise specifically focused on wastewater treatment on hog farms, is utilizing OriginClear’s technology. An OriginClear licensee, Depuporc has created a commercial-scale system that can treat 30 tons of wastewater per day: an important step in the process of treating pig manure effluent for the global livestock industry. Eckelberry explained that a 2,500-head dairy farm generates as much waste as the city of Miami. OriginClear’s technology effectively deals with the enormous plumes of pollution – especially ammonia – that are created by these farms. Thanks to OCLN’s ground-breaking technology and systems, sludge water becomes clear water. This technology will allow Spanish pork producers to achieve EU approval and expand their farms.

OriginClear’s business model is to create licensing agreements with diverse industries that create applications of the water-treatment technology (http://ibn.fm/AiWca). Licensees are building products worldwide using OriginClear’s low-energy, chemical-free innovation. Eckelberry noted that OriginClear now has a remarketing agreement that allows the company to take Depuporc’s integrated manure-treatment system using OriginClear’s technology and sell it as an application globally. Looking ahead to 2020, OriginClear will be concentrating on acquiring companies to facilitate growth and secure a more dominant position in the decentralized water space.

OriginClear’s inventive technologies offer a myriad of benefits to business owners. Not only do they enable businesses and point-of-use water users to be more independent and self-reliant, they can also improve their asset value. Additionally, the company is helping businesses decrease their carbon footprint by cleaning their water on-site. OriginClear is also protecting the water going into the ground. All these efforts result in improving the environment and people’s health and well-being.

OriginClear’s mission is to add value to businesses. The company provides modular water-purification systems, storage systems, pump stations, and wastewater systems, as well as control systems. With a focus on commercial and industrial applications, the company serves the commercial, real estate, hospitality, food and beverage, and business parks industries, as well as the industrial, oil/gas/energy, agriculture, pharmaceutical and manufacturing spaces.

OriginClear is leading decentralized water-treatment innovation with its Modular Water Systems™ product line for treatment and conveyance. These systems can be trucked on-site quickly and inexpensively and utilize unique, super-durable materials (http://ibn.fm/qkdLc). Additionally, OriginClear is commercializing Electro Water Separation™ with Advanced Oxidation™, which is a patented, chemical-free technology that cleans extremely dirty, oily water and removes microtoxins.

OriginClear also helps corporations improve their environmental, social and governance (ESG) standings with world-class water management. Of note is that 35% of all treated water is lost during conveyance because of failing infrastructure. Consequently, untreated “dirty” water substantially increases carbon footprint and adds to global warming. OriginClear helps businesses improve their ESG ratings by treating water onsite before conveyance to reduce the risk of treated water being lost during conveyance.

OriginClear continues to execute on its mission to restore water to its original pure condition by strengthening its marketing efforts and telling the story of its innovative products. With the significant advancements and test results being made, the company offers investors the potential for significant ROI.

Headquartered in Los Angeles, California, OriginClear offers revolutionary products that effectively improve the quality of the planet’s waters by returning them to their original and clear condition. OriginClear’s emphasis is decentralized water wealth, enabling businesses to take their own water into their own hands versus relying on municipalities.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• SGLB president and CEO discusses disruptive 3D metal-printing technology and how it will reconfigure factory operation
• 3D metal printing is recognized as disruptive technology that can enhance numerous industries, including defense operations and capabilities
• Sigma Labs is set to harness benefits of focused efforts from 2019 in the upcoming year
• 3D metal printing is a multibillion-dollar market

Sigma Labs Inc. (NASDAQ: SGLB) President and CEO John Rice recently joined NNW’s Stuart Smith to discuss the company’s disruptive technology (http://ibn.fm/nls82). A leading developer of quality-control software for the commercial 3D-printing industry, SGLB offers PrintRite3D® software: a proprietary, real-time, computer-aided inspection (CAI) technology. The product is unique as the only in-process, quality-assurance software that revolutionizes the commercial 3D metal-printing industry by enabling nondestructive quality control intervention during the production process.

Sigma Labs was founded in 2010 by a team of senior scientists and engineers from Los Alamos Labs who were poised to develop revolutionary parts in metallurgy science. Managed by experts from different science disciplines such as physics, metallurgy, mechanical engineering, optics, artificial intelligence and data science, the company has become the go-to 3D-metal-printing source for quality control disruptive solutions.

While Rice acknowledges that today “disruption” is an overused term among industry practitioners and academics alike, the SGLB CEO notes that 3D printing is a disruptive technology that revolutionizes the way items – everything from consumer products to heavyweight industrial machinery – are created. SGLB technology will help reconfigure how factories operate in the future, transforming the facilities into Internet of Things factories that will be redesigned along the entire value chain, he says.

Among other industries, additive laser powder bed manufacturing (or 3D metal printing) is recognized as a disruptive technology that can considerably enhance all of manufacturing, especially the defense industry’s operations and military capabilities. Offering solutions such as unmanned and autonomous robotic systems, directed-energy weapons, human performance modification and cyber capabilities, 3D printing is set to transform warfare.

3D-printing technology allows on-demand production, improving the supply-chain responsiveness and reducing inventory, obsolescence risks and total costs. In addition, small scale, or “one-off” production, is viable with this technology because no economies of scale are needed, and standardization is no longer a requirement. As the technology matures, parts could be printed on-site from available materials.

Although 3D printing is considered a key technology that enhances the capabilities of the defense industry, a real challenge remains in the quality-control procedures as inspecting and testing complex shapes is costly and difficult. The 3D metal-printing technology has faced significant difficulties in producing highly consistent, repeatable, quality parts.

Sigma Labs’ technology solves this difficulty by allowing the parts to be monitored in real time during the production process while its flagship revolutionary software, PrintRite 3D, is extracting and assessing thermal information when a part is beginning to drift out of specification. The software is able to spot the precursors of quality issues and alert the machine operator, who can stop and make a correction immediately.

Even with quality-control challenges, 3D metal printing is a multibillion-dollar market. Verified Market Research valued the global 3D-printing market at $8.08 billion in 2017 and projected a CAGR of 25.5% from 2018 to 2025, when the market is expected to reach $49.74 billion.

These impressive growth rates have attracted considerable attention from investors, who have been investing heavily in 3D-printing companies, both public and VC backed. The sector’s growth potential could be even more spectacular with Sigma Labs’ technology solving major obstacles that prevent production at scale.

After a year of intense work, Sigma Labs currently has six major enterprise companies – three OEMs and three end users – that will be completing the test-and-evaluation phases of Sigma Labs’ equipment over the next months. SGLB has spent 2019 validating efficacy while moving toward full commercialization and is poised to harvest these efforts in this year.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• Wonderfilm Media Corporation is a new, up-and-coming entertainment production and acquisition house building on its executives’ experience at turning relatively low budgets into much higher gains
• Wonderfilm is establishing a toehold in the growing subscription video on demand industry by providing celebrity-fronted projects to SVoD outlets that are continually searching for more content
• Most importantly, the company is backed by five successful Hollywood producers, who have produced over $1 billion in box office revenue
• Nicolas Cage, John Travolta, Guy Pearce, Felicity Huffman, and Tara Reid are among the celebrities signed to the company’s 2019-2020 project slate

Cord cutters have gained a growing measure of control on-the-go over their entertainment choices thanks to the rise of streaming video services, creating the seeds of a free-the-cable-box future and more democratic approach to film studio production in the process.

British Columbia-based film production house Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) is taking advantage of streaming consumers’ openness to “indie” entertainment options that don’t have the trappings of a blockbuster franchise, bringing developed scripts with celebrity backing to the screen using a strategic budget model that aims to turn significant profits from controlled front-end costs.

A recent NetworkNewsWire editorial noted Wonderfilm’s emergence in a competitive new subscription video on demand (SVoD) market that may rely on newer production companies to feed the belly of the entertainment industry beast as alternatives to higher budget offerings (http://ibn.fm/1iaEh).

“As digital streaming steadily eclipses all other forms of in-home entertainment delivery, an entertainment war has erupted among leading subscription video on demand (SVoD) providers. These streaming wars have opened the gate for newer production companies to step up and cash in by funneling fresh content to hungry SVoDs. The battle has already resulted in some big winners, including film-production companies, such as Wonderfilm Media Corporation,” the editorial states.

Variety magazine reported earlier this year that the largest media companies are spending about $107 billion annually on global content. Wonderfilm productions develop a script and a commitment from a celebrity into a movie pre-sale for an average of about $5 million with about $500,000 to $750,000 of that amount remaining in-house as commissions.

The company retains ownership rights to the film, banking on the potential for profits that will begin to roll in once the revenue terms outlined in the contracts are fulfilled if the films are successful.

The first day cameras start rolling, Wonderfilm begins receiving returns from the production budget that range from $50,000 to $500,000 according to the production line-item fees contracts (http://ibn.fm/vgwQx).

Although the fledgling company is less than two years old, its executives have gained experience employing similar models on previous projects, such as the sleeper hit Get Out and The Hurt Locker. Their work in the film and television industries have also granted them access to the celebrities who have headlined their projects.

Thus far, Wonderfilm’s slate of developed or in-development projects have featured household names such as John Travolta, Guy Pearce, Felicity Huffman, Tara Reid and Nicolas Cage.

For more information, visit the company’s website at www.Wonderfilm.com

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF

• CIIX CEO speaks to attaining profitability in 2020 as company grows revenue
• Subsidiary CBD Biotech and CBD cosmetics instrumental in driving CIIX’s growth
• CIIX leadership focusing on cost cutting, maintaining profitability, and increased revenue with high margin product sales

ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang spoke optimistically about his company’s growth potential in a recent MoneyTV interview with host Donald Baillargeon. Wang said the company would focus in 2020 on building more revenue from high margin products and cutting costs to achieve profitability. He also emphasized the important role subsidiary CBD Biotech and CBD-infused cosmetics products would play in China.

He cited the high gross margins of CBD cosmetics for the company and said the firm would work to bring more of that profitability down to the bottom line through lower costs and restructuring. CIIX offers a variety of products in its line, ranging from hemp wine to CBD-infused cosmetics.

“We can achieve in cosmetic products a 10X to 20X profit margin. That’s quite a big profit,” Wang said in the interview (http://ibn.fm/d7fZH). “Our goal is to make the company healthier by stabilizing it and making it not as reliant on the street for financing.”

Facing competition and regulatory challenges, Wang’s strategy is to increase product sales to consumers in 2020 and increase focus by splitting the company into smaller strategic components labeled the B2B and B2C divisions. The B2C division, he said, would focus on marketing and selling to consumers while the B2B division would be responsible for maximizing revenue to wholesalers and through multi-level social media outlets. Together, their aim is to raise sales, cut costs and achieve profitability.

Its subsidiary CBD Biotech in China will then leverage its main asset: its customer base of 40,000 consumer clients. “We are going to use this database of the 40,000 repeat customers and analyze it with CRM software, and then we will try to analyze how to encourage our customers to buy more of our products,” Wang said.

In an earlier letter to CIIX shareholders, Wang noted CIIX’s intent to streamline its operations and maximize current resources across the board to achieve profit. As it refocuses on its core investor relations business and continues to build on to its industrial hemp-infused product line in China and the U.S., Wang is optimistic. “Although we still have work to do in this regard, with these objectives in mind, with a dedicated and experienced management team, and most importantly, the continued support of our loyal shareholders, we look forward to a healthy FY2020,” Wang added in a news release (http://ibn.fm/9oAEu).

Wang also described the company’s goal to diversify its revenue streams in FY2020. It plans to focus on its core investor relations business as well as continue to expand and market its industrial hemp-infused/CBD products in China and the United States for greater revenues and profits.

CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and educational-related services in Chinese character language sets.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX